{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:24:37Z","timestamp":1791033877927,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/leu.2012.22","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T11:39:35Z","timestamp":1328614775000},"page":"1499-1506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease"],"prefix":"10.1038","volume":"26","author":[{"given":"P","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R S","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"BFleu201222_CR1","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.bbrc.2005.09.150","volume":"338","author":"RJ Roskoski","year":"2005","unstructured":"Roskoski RJ . Structure and regulation of Kit protein-tyrosine kinase\u2014the stem cell factor receptor. Biochem Biophy Res Commun 2005; 338: 1307\u20131315.","journal-title":"Biochem Biophy Res Commun"},{"key":"BFleu201222_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.cb.10.110194.001343","volume":"10","author":"P van der Geer","year":"1994","unstructured":"van der Geer P, Hunter T, Lindberg RA . Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994; 10: 251\u2013337.","journal-title":"Annu Rev Cell Biol"},{"key":"BFleu201222_CR3","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1002\/j.1460-2075.1991.tb04989.x","volume":"10","author":"P Blume-Jensen","year":"1991","unstructured":"Blume-Jensen P, Claesson-Welsh L, Siegbahn A, Zsebo KM, Westermark B, Heldin CH . Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 1991; 10: 4121\u20134128.","journal-title":"EMBO J"},{"key":"BFleu201222_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577\u2013580.","journal-title":"Science"},{"key":"BFleu201222_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","volume":"25","author":"BJ Longley","year":"2001","unstructured":"Longley BJ, Reguera MJ, Ma Y . Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk Res 2001; 25: 571\u2013576.","journal-title":"Leuk Res"},{"key":"BFleu201222_CR6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","volume":"95","author":"A Beghini","year":"2000","unstructured":"Beghini A, Peterlongo P, Ripamonti CB, Larizza L, Cairoli R, Morra E et al. C-kit mutations in core binding factor leukemias. Blood 2000; 95: 726\u2013727.","journal-title":"Blood"},{"key":"BFleu201222_CR7","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560\u201310564.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201222_CR8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","volume":"85","author":"H Kitayama","year":"1995","unstructured":"Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995; 85: 790\u2013798.","journal-title":"Blood"},{"key":"BFleu201222_CR9","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood.V87.8.3117.bloodjournal8783117","volume":"87","author":"X Piao","year":"1996","unstructured":"Piao X, Bernstein A . A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 1996; 87: 3117\u20133123.","journal-title":"Blood"},{"key":"BFleu201222_CR10","first-page":"189","volume":"148","author":"K Hashimoto","year":"1996","unstructured":"Hashimoto K, Tsujimura T, Moriyama Y, Yamatodani A, Kimura M, Tohya K et al. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line. Am J Pathol 1996; 148: 189\u2013200.","journal-title":"Am J Pathol"},{"key":"BFleu201222_CR11","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1182\/blood-2006-10-053058","volume":"110","author":"V Munugalavadla","year":"2007","unstructured":"Munugalavadla V, Sims EC, Borneo J, Chan RJ, Kapur R . Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis. Blood 2007; 110: 1612\u20131620.","journal-title":"Blood"},{"key":"BFleu201222_CR12","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V83.9.2619.2619","volume":"83","author":"T Tsujimura","year":"1994","unstructured":"Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y et al. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 1994; 83: 2619\u20132626.","journal-title":"Blood"},{"key":"BFleu201222_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472\u2013480.","journal-title":"N Engl J Med"},{"key":"BFleu201222_CR14","first-page":"1115","volume":"1","author":"MJ Frost","year":"2002","unstructured":"Frost MJ, Ferrao PT, Hughes TP, Ashman LK . Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther 2002; 1: 1115\u20131124.","journal-title":"Mol Cancer Ther"},{"key":"BFleu201222_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","volume":"99","author":"Y Ma","year":"2002","unstructured":"Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002; 99: 1741\u20131744.","journal-title":"Blood"},{"key":"BFleu201222_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ccr.2011.07.016","volume":"20","author":"RS Mali","year":"2011","unstructured":"Mali RS, Ramdas B, Ma P, Shi J, Munugalavadla V, Sims E et al. Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL. Cancer Cell 2011; 20: 357\u2013369.","journal-title":"Cancer Cell"},{"key":"BFleu201222_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.exphem.2007.11.008","volume":"36","author":"V Munugalavadla","year":"2008","unstructured":"Munugalavadla V, Sims EC, Chan RJ, Lenz SD, Kapur R . Requirement for p85alpha regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KIT. Exp Hematol 2008; 36: 301\u2013308.","journal-title":"Exp Hematol"},{"key":"BFleu201222_CR18","doi-asserted-by":"publisher","first-page":"11686","DOI":"10.1074\/jbc.M207068200","volume":"278","author":"BL Tan","year":"2003","unstructured":"Tan BL, Hong L, Munugalavadla V, Kapur R . Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem 2003; 278: 11686\u201311695.","journal-title":"J Biol Chem"},{"key":"BFleu201222_CR19","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1128\/MCB.24.3.1401-1410.2004","volume":"24","author":"L Hong","year":"2004","unstructured":"Hong L, Munugalavadla V, Kapur R . c-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways. Mol Cell Biol 2004; 24: 1401\u20131410.","journal-title":"Mol Cell Biol"},{"key":"BFleu201222_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","volume":"7","author":"MG Mohi","year":"2005","unstructured":"Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 2005; 7: 179\u2013191.","journal-title":"Cancer Cell"},{"key":"BFleu201222_CR21","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1182\/blood-2007-09-115477","volume":"112","author":"N Harir","year":"2008","unstructured":"Harir N, Boudot C, Friedbichler K, Sonneck K, Kondo R, Martin-Lanneree S et al. Oncogenic Kit controls neoplastic mast cell growth through a Stat5\/PI3-kinase signaling cascade. Blood 2008; 112: 2463\u20132473.","journal-title":"Blood"},{"key":"BFleu201222_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/onc.2009.320","volume":"29","author":"G Monsel","year":"2010","unstructured":"Monsel G, Ortonne N, Bagot M, Bensussan A, Dumaz N . c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene 2010; 29: 227\u2013236.","journal-title":"Oncogene"},{"key":"BFleu201222_CR23","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood.V96.12.3734","volume":"96","author":"JL Gommerman","year":"2000","unstructured":"Gommerman JL, Sittaro D, Klebasz NZ, Williams DA, Berger SA . Differential stimulation of c-Kit mutants by membrane-bound and soluble Steel Factor correlates with leukemic potential. Blood 2000; 96: 3734\u20133742.","journal-title":"Blood"},{"key":"BFleu201222_CR24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1182\/blood.V100.4.1294.h81602001294_1294_1301","volume":"100","author":"S Maddens","year":"2002","unstructured":"Maddens S, Charruyer A, Plo I, Dubreuil P, Berger S, Salles B et al. Kit signaling inhibits the sphingomyelin-ceramide pathway through PLC gamma 1: implication in stem cell factor radioprotective effect. Blood 2002; 100: 1294\u20131301.","journal-title":"Blood"},{"key":"BFleu201222_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/j.1460-2075.1995.tb07023.x","volume":"14","author":"H Serve","year":"1995","unstructured":"Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P . Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J 1995; 14: 473\u2013483.","journal-title":"EMBO J"},{"key":"BFleu201222_CR26","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1093\/emboj\/17.21.6250","volume":"17","author":"I Timokhina","year":"1998","unstructured":"Timokhina I, Kissel H, Stella G, Besmer P . Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J 1998; 17: 6250\u20136262.","journal-title":"EMBO J"},{"key":"BFleu201222_CR27","doi-asserted-by":"publisher","first-page":"27450","DOI":"10.1074\/jbc.272.43.27450","volume":"272","author":"D Linnekin","year":"1997","unstructured":"Linnekin D, DeBerry CS, Mou S . Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. J Biol Chem 1997; 272: 27450\u201327455.","journal-title":"J Biol Chem"},{"key":"BFleu201222_CR28","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1038\/sj.onc.1202929","volume":"18","author":"J Lennartsson","year":"1999","unstructured":"Lennartsson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L . Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor\/c-kit mediated activation of the Ras\/MAP kinase pathway and c-fos induction. Oncogene 1999; 18: 5546\u20135553.","journal-title":"Oncogene"},{"issue":"Part 1","key":"BFleu201222_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/bj3410211","volume":"341","author":"K Thommes","year":"1999","unstructured":"Thommes K, Lennartsson J, Carlberg M, Ronnstrand L . Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit\/stem cell factor receptor. Biochem J 1999; 341 (Part 1): 211\u2013216.","journal-title":"Biochem J"},{"key":"BFleu201222_CR30","doi-asserted-by":"publisher","first-page":"44544","DOI":"10.1074\/jbc.M404085200","volume":"279","author":"J Lennartsson","year":"2004","unstructured":"Lennartsson J, Shivakrupa R, Linnekin D . Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit. J Biol Chem 2004; 279: 44544\u201344553.","journal-title":"J Biol Chem"},{"key":"BFleu201222_CR31","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1182\/blood.V96.10.3422","volume":"96","author":"RF Duarte","year":"2000","unstructured":"Duarte RF, Frank DA . SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways. Blood 2000; 96: 3422\u20133430.","journal-title":"Blood"},{"key":"BFleu201222_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","volume":"31","author":"D Linnekin","year":"1999","unstructured":"Linnekin D . Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol 1999; 31: 1053\u20131074.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFleu201222_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jlb.67.2.135","volume":"67","author":"M Boissan","year":"2000","unstructured":"Boissan M, Feger F, Guillosson JJ, Arock M . c-Kit and c-kit mutations in mastocytosis and other hematological diseases. J Leukoc Biol 2000; 67: 135\u2013148.","journal-title":"J Leukoc Biol"},{"key":"BFleu201222_CR34","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","volume":"101","author":"M Benekli","year":"2003","unstructured":"Benekli M, Baer MR, Baumann H, Wetzler M . Signal transducer and activator of transcription proteins in leukemias. Blood 2003; 101: 2940\u20132954.","journal-title":"Blood"},{"key":"BFleu201222_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL . The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2: 489\u2013501.","journal-title":"Nat Rev Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201222","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T10:47:54Z","timestamp":1686739674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFleu201222"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.22","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]},"assertion":[{"value":"3 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}